Market open

Innoviva/INVA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Innoviva

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Ticker

INVA
Trading on

Industry

Pharmaceuticals

Employees

112

Innoviva Metrics

BasicAdvanced
$1.2B
Market cap
9.63
P/E ratio
$2.05
EPS
0.57
Beta
-
Dividend rate
$1.2B
0.57
$19.90
$12.22
541K
12.702
11.025
78.005
78.322
7.26%
8.52%
23.83%
9.628
3.798
1.86
2.87
7.965
13.80%
-22.53%
-3.30%
-5.72%

What the Analysts think about Innoviva

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Innoviva stock.

Innoviva Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Innoviva Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy INVA

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Innoviva stock?

Innoviva (INVA) has a market cap of $1.2B as of October 08, 2024.

What is the P/E ratio for Innoviva stock?

The price to earnings (P/E) ratio for Innoviva (INVA) stock is 9.63 as of October 08, 2024.

Does Innoviva stock pay dividends?

No, Innoviva (INVA) stock does not pay dividends to its shareholders as of October 08, 2024.

When is the next Innoviva dividend payment date?

Innoviva (INVA) stock does not pay dividends to its shareholders.

What is the beta indicator for Innoviva?

Innoviva (INVA) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.